Lupin wins FDA approval for generic seizure drug
Lupin’s levetiracetam tablets are the AB-rated generic equivalent of UCB Pharmaceuticals’s Keppra tablets, indicated as adjunctive therapy in the treatment of certain types of seizures associated with epilepsy.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.